×
About 3,295 results

ALLMedicine™ Hormonal Contraception Center

Research & Reviews  1,495 results

Meningiomas in Gynecology and Reproduction: an Updated Overview for Clinical Practice.
https://doi.org/10.1007/s43032-021-00606-2 10.1056/NEJM200101113440207 10.1002/1097-0142(19930801)72:3<639::AID-CNCR2820720304>3.0.CO;2-P 10.1111/j.1365-2265.1994.tb02557.x 10.1016/s0039-128x(00)00193-8 10.1007/s00401-016-1545-1 10.1148/radiol.2016160218 10.3171/2014.7.JNS131644 10.1093/neuros/nyy009 10.1093/neuonc/not330 10.1002/ijc.21255 10.1007/s11060-010-0386-3 10.1007/BF01406053 10.3171/jns.1979.50.4.0499 10.1055/s-2008-1054147 10.1007/BF00314289 10.1007/BF00165601 10.1093/humrep/9.suppl_1.195 10.1007/s00701-019-04084-z 10.2176/nmc.29.619 10.1016/j.wneu.2018.03.187 10.1016/j.wneu.2016.10.058 10.1001/archneurpsyc.1950.02310220078008 10.1016/j.wneu.2018.02.038 10.1158/1055-9965.EPI-08-0406 10.1007/s00701-017-3146-8 10.1007/s11060-017-2656-9 10.1136/jnnp.21.2.89 10.1093/jnci/84.17.1346 10.1080/cmt.6.4.285.292 10.1515/med-2017-0029 10.1056/NEJMoa070972 10.1016/j.ejca.2014.02.018 10.1007/s11102-019-01004-3 10.1586/ecp.11.1 10.1093/neuonc/nou304 10.1056/NEJMoa071453 10.1159/000488106 10.1053/sper.2001.29038 10.1113/jphysiol.1988.sp017082 10.1097/ANA.0000000000000029 10.1186/s12916-017-0845-1 10.1001/jamapediatrics.2014.3351 10.1016/j.ajog.2016.01.004 10.1097/00000542-200202000-00041 10.1016/j.ajogmf.2020.100256 10.1093/neuonc/nou019 10.1016/j.wneu.2020.07.198 10.1002/jmri.26317 10.1007/s11060-014-1427-0 10.1016/j.ijgo.2008.11.037 10.3171/2014.11.JNS14522 10.1186/1471-2407-6-152 10.1158/1055-9965.EPI-10-0447 10.3171/jns.2003.99.5.0848 10.1002/ijc.25184 10.1159/000338081 10.1002/ijc.21950 10.1007/s10552-010-9634-2 10.4140/TCP.n.2016.500 10.1007/s00701-018-03782-4 10.1111/j.1365-2125.2011.04031.x 10.1093/annonc/mdx763 10.1007/s00701-015-2532-3 10.1016/j.neuchi.2015.05.002 10.1007/s00701-010-0787-2 10.1016/j.wneu.2017.03.013 10.1016/j.respe.2020.01.004 10.1007/s00701-019-03848-x 10.1016/s0015-0282(97)00189-1 10.3171/jns.1991.74.6.0861 10.1227/00006123-199404000-00022 10.23736/S0390-5616.16.03243-4 10.1097/01.ede.0000165392.35273.d4 10.1097/01.AOG.0000220502.77153.5a 10.1371/journal.pone.0083261 10.1002/ijc.20776 10.1038/sj.bjc.6604445 10.1002/cncr.22783 10.1016/j.maturitas.2003.09.031 10.1097/01.gme.0000188735.61994.5b 10.1007/s12253-018-00569-x 10.1016/j.ejca.2015.05.007 10.1016/j.endonu.2012.07.004 10.1056/NEJMc071938 10.1016/j.jocn.2010.01.036 10.1080/09513590.2017.1395839 10.1111/and.12550 10.1023/a:1006158514866
Reproductive Sciences (Thousand Oaks, Calif.); Girardelli S, Albano L et. al.

May 10th, 2021 - There is various evidence to suggest a relationship between female hormones and meningiomas; as clinicians, we often come to face challenging situations involving female patients diagnosed with meningiomas during the post-pubertal phases of their ...

Differential risks of changes in seizure frequency with transitions between hormonal an...
https://doi.org/10.1016/j.yebeh.2021.108011
Epilepsy & Behavior : E&B; Herzog AG, Mandle HB et. al.

May 8th, 2021 - This prospective, observational, cohort study of 101 women with epilepsy (WWE) assesses the seizure safety of systemic hormonal contraception (HC) versus non-HC (NHC). It reports risks of changes in seizure frequency associated with transition fro...

Examining the effect of unintended pregnancy on health utility using four measures.
https://doi.org/10.1016/j.contraception.2021.04.019
Contraception Chatroux L, Darney BG et. al.

May 3rd, 2021 - We measured women's preferences for avoiding an unintended pregnancy. We determined if young age (<25) was associated with lowest utility with an unintended pregnancy. We conducted a cross sectional study of women presenting for hormonal contracep...

Contraindications to Hormonal Contraception Among Postpartum Women in Texas.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055194
Obstetrics and Gynecology; Coleman-Minahan K, Ela EJ et. al.

Apr 8th, 2021 - To examine the prevalence of contraindications to hormonal contraception among postpartum women. Low-income postpartum women who planned to delay childbearing for 2 years or longer after delivery were recruited for a prospective cohort study from ...

Microarray patches: Breaking down the barriers to contraceptive care and HIV prevention...
https://doi.org/10.1016/j.addr.2021.04.002
Advanced Drug Delivery Reviews; Paredes AJ, Ramöller IK et. al.

Apr 8th, 2021 - Despite the existence of a variety of contraceptive products for women, as well as decades of research into the prevention and treatment of human immunodeficiency virus (HIV), there is still a globally unmet need for easily accessible, acceptable,...

see more →

Guidelines  35 results

Managing thromboembolic risk with menopausal hormone therapy and hormonal contraception...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200366
Maturitas Ramírez I, De la Viuda E et. al.

Jun 5th, 2020 - COVID-19 is associated with a systemic inflammatory response with activation of coagulation in symptomatic patients. The possibility of coagulopathies in peri- and postmenopausal women taking estrogen therapies makes it necessary to consider antit...

Update to U.S. Medical Eligibility Criteria for Contraceptive Use, 2016: Updated Recomm...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147901
MMWR. Morbidity and Mortality Weekly Report; Tepper NK, Curtis KM et. al.

Apr 9th, 2020 - "U.S. Medical Eligibility Criteria for Contraceptive Use" (U.S. MEC) 2016 provides evidence-based guidance for the safe use of contraceptive methods among U.S. women with certain characteristics or medical conditions (1). The U.S. MEC is adapted f...

Over-the-Counter Access to Hormonal Contraception: ACOG Committee Opinion Summary, Number 788
https://journals.lww.com/greenjournal/Fulltext/2019/10000/Over_the_Counter_Access_to_Hormonal_Contraception_.41.aspx
Obstetrics & Gynecology;

Sep 24th, 2019 - ABSTRACT: Barriers to access are one reason for inconsistent or nonuse of contraception. The requirement for a prescription can be an obstacle for some contraceptive users. Several studies have demonstrated that women are capable of using self-scr...

Fertility preservation, contraception and menopause hormone therapy in women treated fo...
https://doi.org/10.1016/j.ejca.2019.04.018
European Journal of Cancer (Oxford, England : 1990); Rousset-Jablonski C, Selle F et. al.

Jun 6th, 2019 - Rare ovarian tumours include complex borderline ovarian tumours, sex-cord tumours, germ cell tumours and rare epithelial tumours. Indications and modalities of fertility preservation (FP), infertility management, contraindications for hormonal con...

Center for Male Contraceptive Research & Development
https://www.malecontraception.center/

Mar 25th, 2019 - The Center for Male Contraceptive Research & Development is your official source for information and regular updates on Male Hormonal Contraception

see more →

Drugs  7 results see all →

Clinicaltrials.gov  1,593 results

Meningiomas in Gynecology and Reproduction: an Updated Overview for Clinical Practice.
https://doi.org/10.1007/s43032-021-00606-2 10.1056/NEJM200101113440207 10.1002/1097-0142(19930801)72:3<639::AID-CNCR2820720304>3.0.CO;2-P 10.1111/j.1365-2265.1994.tb02557.x 10.1016/s0039-128x(00)00193-8 10.1007/s00401-016-1545-1 10.1148/radiol.2016160218 10.3171/2014.7.JNS131644 10.1093/neuros/nyy009 10.1093/neuonc/not330 10.1002/ijc.21255 10.1007/s11060-010-0386-3 10.1007/BF01406053 10.3171/jns.1979.50.4.0499 10.1055/s-2008-1054147 10.1007/BF00314289 10.1007/BF00165601 10.1093/humrep/9.suppl_1.195 10.1007/s00701-019-04084-z 10.2176/nmc.29.619 10.1016/j.wneu.2018.03.187 10.1016/j.wneu.2016.10.058 10.1001/archneurpsyc.1950.02310220078008 10.1016/j.wneu.2018.02.038 10.1158/1055-9965.EPI-08-0406 10.1007/s00701-017-3146-8 10.1007/s11060-017-2656-9 10.1136/jnnp.21.2.89 10.1093/jnci/84.17.1346 10.1080/cmt.6.4.285.292 10.1515/med-2017-0029 10.1056/NEJMoa070972 10.1016/j.ejca.2014.02.018 10.1007/s11102-019-01004-3 10.1586/ecp.11.1 10.1093/neuonc/nou304 10.1056/NEJMoa071453 10.1159/000488106 10.1053/sper.2001.29038 10.1113/jphysiol.1988.sp017082 10.1097/ANA.0000000000000029 10.1186/s12916-017-0845-1 10.1001/jamapediatrics.2014.3351 10.1016/j.ajog.2016.01.004 10.1097/00000542-200202000-00041 10.1016/j.ajogmf.2020.100256 10.1093/neuonc/nou019 10.1016/j.wneu.2020.07.198 10.1002/jmri.26317 10.1007/s11060-014-1427-0 10.1016/j.ijgo.2008.11.037 10.3171/2014.11.JNS14522 10.1186/1471-2407-6-152 10.1158/1055-9965.EPI-10-0447 10.3171/jns.2003.99.5.0848 10.1002/ijc.25184 10.1159/000338081 10.1002/ijc.21950 10.1007/s10552-010-9634-2 10.4140/TCP.n.2016.500 10.1007/s00701-018-03782-4 10.1111/j.1365-2125.2011.04031.x 10.1093/annonc/mdx763 10.1007/s00701-015-2532-3 10.1016/j.neuchi.2015.05.002 10.1007/s00701-010-0787-2 10.1016/j.wneu.2017.03.013 10.1016/j.respe.2020.01.004 10.1007/s00701-019-03848-x 10.1016/s0015-0282(97)00189-1 10.3171/jns.1991.74.6.0861 10.1227/00006123-199404000-00022 10.23736/S0390-5616.16.03243-4 10.1097/01.ede.0000165392.35273.d4 10.1097/01.AOG.0000220502.77153.5a 10.1371/journal.pone.0083261 10.1002/ijc.20776 10.1038/sj.bjc.6604445 10.1002/cncr.22783 10.1016/j.maturitas.2003.09.031 10.1097/01.gme.0000188735.61994.5b 10.1007/s12253-018-00569-x 10.1016/j.ejca.2015.05.007 10.1016/j.endonu.2012.07.004 10.1056/NEJMc071938 10.1016/j.jocn.2010.01.036 10.1080/09513590.2017.1395839 10.1111/and.12550 10.1023/a:1006158514866
Reproductive Sciences (Thousand Oaks, Calif.); Girardelli S, Albano L et. al.

May 10th, 2021 - There is various evidence to suggest a relationship between female hormones and meningiomas; as clinicians, we often come to face challenging situations involving female patients diagnosed with meningiomas during the post-pubertal phases of their ...

Differential risks of changes in seizure frequency with transitions between hormonal an...
https://doi.org/10.1016/j.yebeh.2021.108011
Epilepsy & Behavior : E&B; Herzog AG, Mandle HB et. al.

May 8th, 2021 - This prospective, observational, cohort study of 101 women with epilepsy (WWE) assesses the seizure safety of systemic hormonal contraception (HC) versus non-HC (NHC). It reports risks of changes in seizure frequency associated with transition fro...

Examining the effect of unintended pregnancy on health utility using four measures.
https://doi.org/10.1016/j.contraception.2021.04.019
Contraception Chatroux L, Darney BG et. al.

May 3rd, 2021 - We measured women's preferences for avoiding an unintended pregnancy. We determined if young age (<25) was associated with lowest utility with an unintended pregnancy. We conducted a cross sectional study of women presenting for hormonal contracep...

Contraindications to Hormonal Contraception Among Postpartum Women in Texas.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055194
Obstetrics and Gynecology; Coleman-Minahan K, Ela EJ et. al.

Apr 8th, 2021 - To examine the prevalence of contraindications to hormonal contraception among postpartum women. Low-income postpartum women who planned to delay childbearing for 2 years or longer after delivery were recruited for a prospective cohort study from ...

Microarray patches: Breaking down the barriers to contraceptive care and HIV prevention...
https://doi.org/10.1016/j.addr.2021.04.002
Advanced Drug Delivery Reviews; Paredes AJ, Ramöller IK et. al.

Apr 8th, 2021 - Despite the existence of a variety of contraceptive products for women, as well as decades of research into the prevention and treatment of human immunodeficiency virus (HIV), there is still a globally unmet need for easily accessible, acceptable,...

see more →

News  165 results

OTC hormonal contraception: An important goal in the fight for reproductive justice
https://www.mdedge.com/obgyn/article/212850/contraception/otc-hormonal-contraception-important-goal-fight-reproductive/page/0/1?channel=61

Nov 21st, 2019 - We need to invest in preventing unplanned pregnancy Currently, hormonal contraception is covered by health insurance under the ACA, with some caveats. Without a prescription, patients may have to pay full price for their contraception.

UK Guidelines Quiz – Menopause: Diagnosis and Management
https://www.medscape.com/viewarticle/919637_3

Oct 17th, 2019 - NICE states that the following may be diagnosed without laboratory tests in otherwise healthy women aged over 45 years with menopausal symptoms: perimenopause based on vasomotor symptoms and irregular periods; menopause in women who have not had a...

Over-the-Counter Access to Hormonal Contraception: ACOG Committee Opinion Summary, Number 788
https://journals.lww.com/greenjournal/Fulltext/2019/10000/Over_the_Counter_Access_to_Hormonal_Contraception_.41.aspx
Obstetrics & Gynecology;

Sep 24th, 2019 - ABSTRACT: Barriers to access are one reason for inconsistent or nonuse of contraception. The requirement for a prescription can be an obstacle for some contraceptive users. Several studies have demonstrated that women are capable of using self-scr...

WHO: All Forms of Contraception OK for Women at High HIV Risk
https://www.medpagetoday.com/hivaids/hivaids/81891

Aug 29th, 2019 - Women at high risk for HIV infection can use any form of reversible hormonal contraception without any restrictions, including progestogen-only injectables, implants, and intrauterine devices (IUDs), the World Health Organization (WHO) said. All f...

see more →